(Q30231417)

11 June 2017

2 references

23 October 2022

Avian influenza virus infections in humans (English)

1 reference

11 June 2017

1 reference

2

0 references

Samson S Y Wong

series ordinal

1

object named as

Samson S Y Wong

1 reference

11 June 2017

language of work or name

English

0 references

publication date

1 January 2006

2 references

11 June 2017

23 October 2022

2 references

11 June 2017

23 October 2022

129

1 reference

11 June 2017

issue

1

1 reference

11 June 2017

page(s)

156-168

1 reference

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

11 June 2017

cites work

1 reference

12 December 2020

Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand.

1 reference

12 December 2020

Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998.

1 reference

12 December 2020

Avian H5N1 influenza in cats

1 reference

12 December 2020

Probable tiger-to-tiger transmission of avian influenza H5N1.

1 reference

12 December 2020

Experience with oseltamivir for infants younger than 1 year old in Japan

1 reference

12 December 2020

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

1 reference

12 December 2020

Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses

1 reference

12 December 2020

The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.

1 reference

12 December 2020

Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.

1 reference

12 December 2020

Human infection with influenza H9N2.

1 reference

12 December 2020

Conjunctivitis in human beings caused by influenza A virus of seals

1 reference

12 December 2020

Influenza A H5N1 replication sites in humans

1 reference

12 December 2020

Oseltamivir: a review of its use in influenza

1 reference

12 December 2020

Avian Influenza in Hong Kong 1997–2002

1 reference

12 December 2020

Molecular basis for the generation in pigs of influenza A viruses with pandemic potential

1 reference

12 December 2020

Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells

1 reference

12 December 2020

Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia

1 reference

12 December 2020

Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model

1 reference

12 December 2020

Human illness from avian influenza H7N3, British Columbia

1 reference

12 December 2020

Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus

1 reference

12 December 2020

Oseltamivir phosphate in infants under 1 year of age with influenza infection

1 reference

12 December 2020

Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine

1 reference

12 December 2020

Re-emergence of fatal human influenza A subtype H5N1 disease

1 reference

12 December 2020

WHO urges regional offices to stockpile flu drug for staff

1 reference

12 December 2020

Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection.

1 reference

12 December 2020

Medical treatment of viral pneumonia including SARS in immunocompetent adult

1 reference

12 December 2020

Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies

1 reference

12 December 2020

Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission

1 reference

12 December 2020

Avian influenza H5N1 in tigers and leopards

1 reference

12 December 2020

Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice

1 reference

12 December 2020

Avian influenza virus isolated from a woman with conjunctivitis

1 reference

12 December 2020

Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir

1 reference

12 December 2020

Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong.

1 reference

12 December 2020

UK stocks up on antiviral drug to tackle flu outbreak

1 reference

12 December 2020

Evidence of airborne transmission of the severe acute respiratory syndrome virus.

1 reference

12 December 2020

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

12 December 2020

Avian influenza A (H5N1) in 10 patients in Vietnam

1 reference

12 December 2020

Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.

1 reference

12 December 2020

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

12 December 2020

Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes

1 reference

12 December 2020

Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand

1 reference

12 December 2020

Evolution of H5N1 avian influenza viruses in Asia

1 reference

12 December 2020

Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia

1 reference

12 December 2020

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

1 reference

12 December 2020

Plaque inhibition assay for drug susceptibility testing of influenza viruses

1 reference

12 December 2020

Human disease from influenza A (H5N1), Thailand, 2004.

1 reference

12 December 2020

Human and avian influenza viruses target different cell types in cultures of human airway epithelium.

1 reference

12 December 2020

In vitro and in vivo influenza virus-inhibitory effects of viramidine

1 reference

12 December 2020

Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands

1 reference

12 December 2020

Avian influenza A viruses of southern China and Hong Kong: ecological aspects and implications for man

1 reference

12 December 2020

Respiratory infections during SARS outbreak, Hong Kong, 2003

1 reference

12 December 2020

Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity

1 reference

12 December 2020

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

1 reference

12 December 2020

Evaluation of disinfectants with the addition of antifreezing compounds against nonpathogenic H7N2 avian influenza virus.

1 reference

12 December 2020

Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice.

1 reference

12 December 2020

Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma

1 reference

12 December 2020

Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia?

1 reference

12 December 2020

The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses

1 reference

12 December 2020

Pathology of fatal human infection associated with avian influenza A H5N1 virus

1 reference

12 December 2020

Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals

1 reference

12 December 2020

Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers

1 reference

12 December 2020

Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults

1 reference

12 December 2020

Influenza virus neuraminidase inhibitors

1 reference

12 December 2020

Avian influenza H5N1 and healthcare workers

1 reference

12 December 2020

The effect of various disinfectants on detection of avian influenza virus by real time RT-PCR

1 reference

12 December 2020

Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997.

1 reference

12 December 2020

Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics

1 reference

12 December 2020

Direct measurement of the anti-influenza agent zanamivir in the respiratory tract following inhalation

1 reference

12 December 2020

Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104

1 reference

12 December 2020

PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes

1 reference

12 December 2020

Avian influenza A (H5N1) infection in humans

1 reference

12 December 2020

The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies.

1 reference

12 December 2020

The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers.

1 reference

12 December 2020

A case report of fowl plague keratoconjunctivitis

1 reference

12 December 2020

Avian flu: isolation of drug-resistant H5N1 virus.

1 reference

12 December 2020

Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model

1 reference

12 December 2020

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

1 reference

12 December 2020

Single-step multiplex reverse transcription-polymerase chain reaction (RT-PCR) for influenza A virus subtype H5N1 detection

1 reference

12 December 2020

Evolution of the receptor binding phenotype of influenza A (H5) viruses

1 reference

12 December 2020

Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts

1 reference

12 December 2020

Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals

1 reference

12 December 2020

Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003.

1 reference

12 December 2020

Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004

1 reference

12 December 2020

Probable person-to-person transmission of avian influenza A (H5N1)

1 reference

12 December 2020

Differences between influenza virus receptors on target cells of duck and chicken and receptor specificity of the 1997 H5N1 chicken and human influenza viruses from Hong Kong.

1 reference

12 December 2020

Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors

1 reference

12 December 2020

Identifiers

DOI

10.1378/CHEST.129.1.156

1 reference

11 June 2017

0 references

1 reference